StockWatch
·
HomeLiveWeekly
Biotechnology: Pharmaceutical Preparations
OtherJun 16, 2026, 06:07 AM

Alterity Therapeutics Files Form 6-K with Corporate Presentation

AI Summary

Alterity Therapeutics Limited filed a Form 6-K report for the month of June 2026. The filing includes a corporate presentation from June 2026 as an exhibit. The company indicated it files annual reports under Form 20-F. The filing was signed by Julian Babarczy, Chairman, on June 16, 2026.

View SEC Filing
ATHE
Biotechnology: Pharmaceutical Preparations
ALTERITY THERAPEUTICS LTD

Price Impact

More from ATHE

Business Update1d ago, 7:26 AM

Alterity Therapeutics CEO to Attend BTIG Biotech Conference

Business Update1d ago, 6:08 AM

Alterity to Participate in BTIG Biotechnology Conference

Tax & PenaltyJul 9, 6:08 AM

Alterity Therapeutics Receives A$3.98M R&D Tax Incentive

More in Other

XTLB1d ago, 4:12 PM

XTL Biopharmaceuticals Discloses General Risk Factors

VISTJul 16, 4:17 PM

Vista Energy Files 6-K with Forward-Looking Statements Disclaimer

TOPSJul 15, 11:21 AM

TOP SHIPS Files 6-K Referencing Press Release